epiglucan and Leukemia--Myelogenous--Chronic--BCR-ABL-Positive

epiglucan has been researched along with Leukemia--Myelogenous--Chronic--BCR-ABL-Positive* in 1 studies

Other Studies

1 other study(ies) available for epiglucan and Leukemia--Myelogenous--Chronic--BCR-ABL-Positive

ArticleYear
β-Glucan-Induced IL-10 Secretion by Monocytes Triggers Porcine NK Cell Cytotoxicity.
    Frontiers in immunology, 2021, Volume: 12

    Beta-glucans are naturally occurring polysaccharides present in cell walls of fungi, yeast, bacteria, cereals, seaweed, and algae. These microbe-associated molecular patterns (MAMPs) possess immunomodulatory properties. In human, it has been suggested that NK cells can be activated by β-glucans. Here, we aimed to elucidate whether β-glucans modulate porcine NK cell responses

    Topics: Animals; beta-Glucans; Coculture Techniques; Cytotoxicity, Immunologic; Humans; Interleukin-10; K562 Cells; Killer Cells, Natural; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Monocytes; Paracrine Communication; Secretory Pathway; Sus scrofa

2021